INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $612,321 | -12.1% | 19,365 | +13.4% | 0.00% | -33.3% |
Q2 2023 | $696,400 | +39.2% | 17,077 | +27.2% | 0.00% | +50.0% |
Q1 2023 | $500,238 | +1.4% | 13,422 | -5.1% | 0.00% | 0.0% |
Q4 2022 | $493,240 | -38.1% | 14,137 | -0.7% | 0.00% | -60.0% |
Q3 2022 | $797,000 | +47.0% | 14,240 | +36.0% | 0.01% | +66.7% |
Q2 2022 | $542,000 | -40.9% | 10,470 | -17.0% | 0.00% | -50.0% |
Q1 2022 | $917,000 | -62.7% | 12,615 | -39.3% | 0.01% | -64.7% |
Q4 2021 | $2,456,000 | +6.8% | 20,770 | +21.1% | 0.02% | -10.5% |
Q3 2021 | $2,300,000 | -4.0% | 17,145 | +15.9% | 0.02% | -13.6% |
Q2 2021 | $2,395,000 | +95.8% | 14,794 | -2.9% | 0.02% | +69.2% |
Q1 2021 | $1,223,000 | +606.9% | 15,243 | +379.6% | 0.01% | +550.0% |
Q4 2020 | $173,000 | +1822.2% | 3,178 | +601.5% | 0.00% | – |
Q3 2020 | $9,000 | +800.0% | 453 | +754.7% | 0.00% | – |
Q2 2020 | $1,000 | -85.7% | 53 | -79.4% | 0.00% | – |
Q3 2018 | $7,000 | -30.0% | 257 | -31.5% | 0.00% | -100.0% |
Q2 2018 | $10,000 | – | 375 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |